Case Study

Building a Pricing Strategy to Support an Immunotherapy Launch

Six clear plastic test tubes with white measurement markings, one filled with dark liquid, placed on a rack in a laboratory setting.

Situation

A large multinational pharmaceutical company preparing to launch a newly-approved immunotherapy in a highly competitive oncology market sought support defining a pricing and provider channel strategy that could support differentiated positioning at launch. The client needed to understand how the therapy’s clinical value would be perceived across key provider channels, how competitive and reimbursement dynamics could affect pricing flexibility, and how launch pricing and discounts could shape long-term profitability as reimbursement evolves over time.

Approach

HealthQuest developed an integrated pricing and channel strategy grounded in clinical differentiation, commercial dynamics, and reimbursement considerations. The work began with an assessment of the therapy’s positioning relative to current and emerging therapies, generating insight into the patient segments most likely to benefit, potential total cost of care impact, physician-perceived value, and exposure to competitive pressure in a concentrated oncology market.

Targeted market intelligence was then gathered across community oncology, integrated delivery networks, and academic cancer centers, supplemented by expert input on reimbursement, formulary access, pathway inclusion, and NCCN considerations. These findings informed pricing recommendations linked to perceived clinical value, while competitive benchmarking and scenario modeling were used to estimate channel-specific discounting needed to support adoption.

The result was a channel-specific pricing and discount strategy, supported by provider economics and revenue modeling across a range of pricing and adoption scenarios.

Impact

The engagement provided the client with a data-driven pricing and channel strategy to support launch. The work clarified how the therapy’s clinical and economic value could be communicated across key stakeholder groups, identified the provider segments most critical to early uptake, and outlined pricing and contracting approaches to help sustain value amid competitive and reimbursement pressure.

HealthQuest’s pricing and discount recommendations provided the client’s commercial team with pressure-tested pricing and discount parameters for engagement with provider accounts, strengthening the organization’s foundation for launch planning and initial market access execution.

Client


Pharma & Biotech

Primary Capability


Market Access & Pricing